# Efficacy and Safety of D-chiro-inositol in Obese Patients

> **NCT05348941** · NA · COMPLETED · sponsor: **Lo.Li.Pharma s.r.l** · enrollment: 44 (actual)

## Conditions studied

- Insulin Resistance

## Interventions

- **DIETARY_SUPPLEMENT:** TECADRIOL

## Key facts

- **NCT ID:** NCT05348941
- **Lead sponsor:** Lo.Li.Pharma s.r.l
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-28
- **Primary completion:** 2022-09-27
- **Final completion:** 2023-11-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05348941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05348941, "Efficacy and Safety of D-chiro-inositol in Obese Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05348941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*